Company profile BCDA
After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0. BioCardia expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 0 |
| 2019 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 36 inf% YoY inf% QoQ | 208 inf% YoY 477.8% QoQ |
| 2021 | 110 inf% YoY -47.1% QoQ | 90 inf% YoY -18.2% QoQ | 20 -44.4% YoY -77.8% QoQ | 101 -51.4% YoY 405.0% QoQ |
| 2022 | 84 -23.6% YoY -16.8% QoQ | 111 23.3% YoY 32.1% QoQ | 89 345.0% YoY -19.8% QoQ | 32 -68.3% YoY -64.0% QoQ |
| 2023 | 65 -22.6% YoY 103.1% QoQ | 35 -68.5% YoY -46.2% QoQ | 116 30.3% YoY 231.4% QoQ | 0 -100.0% YoY -100.0% QoQ |
The average 5 years interest of BioCardia was 4.2 per week. The last year interest of BioCardia compared to the last 5 years has changed by 6.67%. This is something to be checked. This didn't exist 5 years ago.
There is not enough data for CardiAMP therapy to provide analysis
There is not enough data for CardiAMP therapy to provide correlation calculation
There is not enough data for CardiAMP therapy to provide analysis
There is not enough data for BioCardia heart failure to provide analysis
There is not enough data for BioCardia heart failure to provide correlation calculation
There is not enough data for BioCardia heart failure to provide analysis
After 39 days of this quarter the interest is at 100.0. Based on that we can calculate that during remaining 52 days it will total up to 233.0. Mesenchymal cell therapy expected interest is significantly higher compared to previous quarter (+482.5%) and same quarter last year (+50.3%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 112 | 204 82.1% QoQ | 84 -58.8% QoQ | 129 53.6% QoQ |
| 2020 | 153 36.6% YoY 18.6% QoQ | 166 -18.6% YoY 8.5% QoQ | 163 94.0% YoY -1.8% QoQ | 139 7.8% YoY -14.7% QoQ |
| 2021 | 111 -27.5% YoY -20.1% QoQ | 188 13.3% YoY 69.4% QoQ | 134 -17.8% YoY -28.7% QoQ | 159 14.4% YoY 18.7% QoQ |
| 2022 | 177 59.5% YoY 11.3% QoQ | 107 -43.1% YoY -39.5% QoQ | 117 -12.7% YoY 9.3% QoQ | 151 -5.0% YoY 29.1% QoQ |
| 2023 | 155 -12.4% YoY 2.6% QoQ | 133 24.3% YoY -14.2% QoQ | 87 -25.6% YoY -34.6% QoQ | 40 -73.5% YoY -54.0% QoQ |
| 2024 | 100 -35.5% YoY 150.0% QoQ | - | - | - |
The average 5 years interest of Mesenchymal cell therapy was 10.76 per week. The last year interest of Mesenchymal cell therapy compared to the last 5 years has changed by -18.87%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -23.08%.
There is not enough data for Helix biotherapeutic delivery system to provide analysis
There is not enough data for Helix biotherapeutic delivery system to provide correlation calculation
There is not enough data for Helix biotherapeutic delivery system to provide analysis
There is not enough data for Morph deflectable guides to provide analysis
There is not enough data for Morph deflectable guides to provide correlation calculation
There is not enough data for Morph deflectable guides to provide analysis
There is not enough data for BioCardia careers to provide analysis
There is not enough data for BioCardia careers to provide correlation calculation
There is not enough data for BioCardia careers to provide analysis
There is not enough data for BioCardia reviews to provide analysis
There is not enough data for BioCardia reviews to provide correlation calculation
There is not enough data for BioCardia reviews to provide analysis
There is not enough data for BioCardia California to provide analysis
There is not enough data for BioCardia California to provide correlation calculation
There is not enough data for BioCardia California to provide analysis
After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 193 |
| 2019 | 239 23.8% QoQ | 174 -27.2% QoQ | 166 -4.6% QoQ | 158 -18.1% YoY -4.8% QoQ |
| 2020 | 43 -82.0% YoY -72.8% QoQ | 122 -29.9% YoY 183.7% QoQ | 174 4.8% YoY 42.6% QoQ | 264 67.1% YoY 51.7% QoQ |
| 2021 | 144 234.9% YoY -45.5% QoQ | 158 29.5% YoY 9.7% QoQ | 197 13.2% YoY 24.7% QoQ | 193 -26.9% YoY -2.0% QoQ |
| 2022 | 151 4.9% YoY -21.8% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
The average 5 years interest of BioCardia -stock -company was 9.1 per week. The last year interest of BioCardia -stock -company compared to the last 5 years has changed by -100.0%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -100.0%.